Pharming Group's total assets for Q4 2025 were $425.70M, a decrease of -10.15% from the previous quarter. NL:PHARM total liabilities were $189.76M for the fiscal quarter, a -9.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.